The Global Fund recently released the "Technical Brief: Prevent, Detect, and Respond to Mpox," which lists MPXV molecular tests currently compliant with its Quality Assurance standards.

We are thrilled to announce that BioPerfectus is among the seven companies globally recognized. Our featured products include the Monkeypox Virus (MPXV) Fast Real Time PCR Kit and the Monkeypox Virus and Orthopoxvirus Real Time PCR Kit.

Click the link to view the full document:

https://www.theglobalfund.org/media/12435/core_mpox_technicalbrief_en.pdf

• BioPerfectus: Trusted Mpox Kit Supplier Recognized by Leading Organizations
  
  Our kits have played a crucial role in supporting local testing and control efforts across Africa, collaborating with organizations such as the WHO, Africa CDC, the African Union, and ASLM to aid in outbreak containment. The recognition underscores our commitment to providing high-quality monkeypox diagnostic solutions and our rapid response to global health challenges.
  
  
  
•  New Solutions in the Fight Against Mpox
  
  

  We are thrilled to unveil our latest innovations for Mpox detection, designed to offer enhanced stability, ease of use, and cost-effectiveness to healthcare professionals worldwide.

  - BioPerfectus Monkeypox Virus Detection Kit could detect and distinguish Clade I, Clade II, and Clade Ib genotypes, ensuring accurate and reliable results.

  - BioPerfectus Monkeypox Virus Real-Time PCR Kit (Lyophilized Type) uses advanced freeze-dried technology, delivering resistance to temperature fluctuations for consistent performance in varying conditions.

  With these new tools, we aim to empower healthcare professionals in the fight against Mpox. 
  
  

  Discover more about our solutions now:

  https://www.bioperfectus.com/productonelist?C=103